Selectivity of Ligands for Opioid Receptors
Akil H, Young E, Watson SJ (1981) Opiate binding properties of naturally occurring N- and C-terminus modified β-endorphins. Peptides 2: 289–292
Akiyama K, Gee KW, Mosberg HI, Hruby VJ, Yamamura HI (1985) Characterization of [3H][2-D-penicillamine,5-D-penicillamine]-enkephalin binding to 8 opiate receptors in the rat brain and neuroblastoma-glioma hybrid cell line (NG 108–15). Proc Natl Acad Sci USA 82: 2543–2547
Amiche M, Sagan S, Mor A, Delfour A, Nicolas P (1988) Characterization of the receptor binding profile of 3H-dermorphin in the rat brain. Int J Pept Protein Res 32: 506–511
Amiche M, Sagan S, Mor A, Delfour A, Nicolas P (1989) Dermenkephalin (Tyr-D- Met-Phe-His-Leu-Met-AsP-NH2): a potent and fully specific agonist for the δ-opioid receptor. Mol Pharmacol 35: 774–779
Archer S, Seyed-Mozaffari A, Ward S, Kosterlitz HW, Paterson SJ, McKnight AT, Corbett AD (1985) 10-ketonaltrexone and 10-ketooxymorphone. J Med Chem 28:974–976
Berzetei IP, Yamamura HI, Duckies SP (1987) Characterization of rabbit ear artery opioid receptors using a δ–selective agonist and antagonist. Eur J Pharmacol 139: 61–66
Berzetei IP, Fong A, Yamamura HI, Duckies SP (1988) Characterization of ĸ-opioid receptors in the rabbit ear artery. Eur J Pharmacol 151: 449–455
Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at K opioid receptors. Eur J Pharmacol 144: 405–408
Blumberg H, Dayton HB, George M, Rapaport DN (1961) N-allylnoroxymorphine: a potent narcotic antagonist. Fed Proc 2: 311
Boyle SJ, Meecham KG, Hunter JC, Hughes J (1990) [3H]-CI-977: a highly selective ligand for the ĸ-opioid receptor in both guinea-pig and rat forebrain. Mol Neuropharmacol 1:23–29
Chang KJ, Wei ET, Killian A, Chang JK (1983) Potent morphiceptin analogs: structure activity relationships and morphine-like properties. J Pharmacol Exp Ther 227: 403–408
Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the ĸ opioid receptor. Science 215: 413–415
Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108
Clark CR, Birchmore B, Sharif NA, Hunter JC, Hill RG, Hughes J (1988) PD117302: a selective agonist for the ĸ-opioid receptor. Br J Pharmacol 93:618–626
Cohen ML, Shuman RT, Osborne JJ, Gesellchen PD (1986) Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY 281217. J Pharmacol Exp Ther 238: 769–771
Corbett AD, Paterson SJ, McKnight AT, Magnan J, Kosterlitz HW (1982) Dynorphin-(l–8) and dynorphin-(l–9) are ligands for the K-subtype of opiate receptor. Nature 299: 79–81
Corbett AD, Gillan MGC, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE (1984) Selectivities of opioid peptide analogues as agonists and antagonists at the δ-receptor. Br J Pharmacol 83: 271–279
Corbett AD, Gillan MGC, Kosterlitz HW, Paterson SJ (1985a) Binding and pharmacological profile of a highly selective ligand for the ĸ-opioid receptor - U-69,593. Br J Pharmacol 86: 704 P
Corbett AD, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE (1985b) Pre-incubation of the guinea-pig myenteric plexus with β-funaltrexamine: discrepancy between binding assays and bioassays. Br J Pharmacol 85: 665–673
Corbett AD, Kosterlitz HW (1986) Bremazocine is an agonist at ĸ-opioid receptors and an antagonist at μ–opioid receptors in the guinea pig myenteric plexus. Br J Pharmacol 89: 245–249
Costa T, Wüster M, Herz A, Shimohigashi Y, Chen H-C, Rodbard D (1985) Receptor binding and biological activity of bivalent enkephalins. Biochem Pharmacol 34: 25–30
Costello GF, Main BG, Barlow JJ, Carroll JA, Shaw JS (1988) A novel series of potent and selective agonists at opioid ĸ-receptors. Eur J Pharmacol 151:475–478
Cotton R, Giles MG, Miller L, Shaw JS, Timms D (1984) ICI 174864: a highly selective antagonist for the opioid δ-receptor. Eur J Pharmacol 97: 331–332
Cotton R, Kosterlitz HW, Paterson SJ, Ranee MJ, Traynor JR (1985) The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the δ-binding site. Br J Pharmacol 84: 927–932
Cox BM, Chavkin C (1983) Comparison of dynorphin-selective kappa-receptors in mouse vas deferens and guinea-pig ileum. Mol Pharmacol 23: 36–43
Delay-Goyet P, Zajac J-M, Rigaudy P, Foucaud B, Roques BP (1985) Comparative binding properties of linear and cyclic δ-selective enkephalin analogues: [3H]-[D- Thr2,Leu5]enkephalyl-Thr6 and [3H]-[D-Pen2,D-Pen5]enkephalin. FEBS Lett 183: 439–443
Delay-Goyet P, Seguin C, Gacel G, Roques BP (1988) [3H]-[D-Ser(O-tert- butyl)2,Leu5]enkephalyl–Thr6 and [3H]–[D-Ser(O-terr-butyl)2,Leu5]enkephalyl- Thr6(O-tert-butyl). Two new enkephalin analogs with both a good selectivity and a high affinity towards δ-opioid binding sites. J Biol Chem 263: 4124–4130
Donnerer J, Oka K, Brossi A, Rice KC, Spector S (1986) Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci USA 83: 4566–4567
Donnerer J, Cardinale G, Coffey J, Lisak CA, Jardine I, Spector S (1987) Chemical characterization and regulation of endogenous morphine and codeine in the rat. J Pharmacol Exp Ther 242: 583–587
Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C, Barra D, Simmaco M, Kreil G (1989) Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc Natl Acad Sci USA 86: 5188–5192
Fischli W, Goldstein A, Hunkapillar MV, Hood LE (1982) Isolation and amino acid sequence analysis of a 4000 dalton dynorphin from porcine pituitary. Proc Natl Acad Sci USA 79: 5435–5437
Gacel G, Fournie–Zaluski MC, Roques BP (1980) Tyr-D-Ser-Gly-Phe-Leu-Thr, a highly selective ligand for δ-opiate receptors. FEBS Lett 118: 245–247
Gacel G, Dauge V, Breuze P, Delay-Goyet P, Roques BP (1988) Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for δ-opioid receptors. J Med Chem 31: 1891–1897
Gairin JE, Jomary C, Prodayrol L, Cros J, Meunier J–C (1986) 125I–DPDYN, monoiodo[D–Pro10]dynorphin(l–ll): a highly radioactive and selective probe for the study of kappa opioid receptors. Biochem Biophys Res Commun 134:1142– 1150
Gillan MGC, Kosterlitz HW, Magnan J (1981) Unexpected antagonism in the rat vas deferens by benzomorphans which are agonists in other pharmacological tests. Br J Pharmacol 72: 13–15
Goldstein A (1987) Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Neurosci 8: 456–459
Goldstein A, James IF (1984) Site-directed alkylation of multiple opioid receptors: II. Pharmacological selectivity. Mol Pharmacol 25: 343–348
Goldstein A, Naidu A (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 36: 265–272
Gubler U, Seeberg PH, Hoffman BJ, Gage LP, Udenfriend S (1982) Molecular cloning establishes proenkephalin as precursor of enkephalin-containing peptides. Nature 295: 206–208
Hambrook JM, Morgan BA, Ranee MJ, Smith CFC (1976) Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262: 782–783
Handa BK, Lane AC, Lord J AH, Morgan BA, Ranee MJ, Smith CFC (1981) Analogues of β-LPH61–64 possessing selective agonist activity at μ-opiate receptors. Eur J Pharmacol 70: 531–540
Hawkins KN, Morelli M, Gulya K, Chang K-J, Yamamura HI (1987) Autoradiographic localization of [3H] [MePhe3,D-Pro4] morphiceptin ([3H]PL O17) to μ-opioid receptors in rat brain. Eur J Pharmacol 133: 351–352
Hawkins KN, Knapp RJ, Lui GK, Gulya K, Kazmierski W, Wan Y-P, Pelto JT, Hruby VJ, Yamamura HI (1989) [3H]-fD-Phe-Cys-Tyr-D-TrP-OrN-Thr-PeN-Thr- NH2] ([3H]CTOP), a potent and highly selective peptide for [i opioid receptors in rat brain. J Pharmacol Exp Ther 248:73–80
Hayes AG, Sheehan MJ, Tyers MB (1985) Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens using β-FNA. Br J Pharmacol 86: 899–904
Henschen A, Lottspeich F, Brantl V, Teschemacher H (1979) Novel opioid peptides derived from casein (β-casomorphins): II. Structure of active components from bovine casein peptone. Hoppe-Seyler’s Z Physiol Chem 360: 1217–1224
Höllt V, Sanchez-Blasquez P, Garzon J (1985) Multiple opioid ligands and receptors in the control of nociception. Philos Trans R Soc Lond [Biol] 308: 299–310
Hughes J, Kosterlitz HW, Leslie FM (1975a) Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br J Pharmacol 53: 371–381
Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR (1975b) Identification of two related peptides from the brain with potent opiate agonist activity. Nature 258: 577–579
Hunter JC, Leighton GE, Meecham KG, Boyle S, Horwell DC, Rees DC, Hughes J (1990) CI–977, a novel and selective agonist for the ĸ-opioid receptor. Br J Pharmacol 101: 183–189
Hurlbut DE, Evans CJ, Barchas JD, Leslie FM (1987) Pharmacological properties of a proenkephalin A-derived peptide: BAM 18. Eur J Pharmacol 138: 359–366
Hutchinson M, Kosterlitz HW, Leslie FM, Waterfield AA, Terenius L (1975) Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br J Pharmacol 55: 541–546
Jin W, Chen X, Chi Z (1987) The choice of opioid receptor subtype in isolated preparations by ohmefentanyl. Sci Sin 30: 176–181
Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S (1982) Cloning and sequence analysis of cDNA for porcine P-neo-endorphin/dynorphin precursor. Nature 298: 245–249
Kazmierski W, Wire WS, Lui GK, Knapp RJ, Shook JE, Burks TF, Yamamura H, Hruby VJ (1988) Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific μ opioid receptor antagonists with greatly reduced binding at somatostatin receptors. J Med Chem 31: 2170–2177
Kilpatrick DL, Wahlstrom A, Lahm H-W, Blacher R, Udenfriend S (1982) Rimorphin, a unique, naturally occurring [Leu]enkephalin-containing peptide found in association with dynorphin and α-neo-endorphin. Proc Natl Acad Sci USA 79: 6480–6483
Kosterlitz HW (1985) Opioid peptides and their receptors. Proc R Soc Lond [Biol] 225: 27–40
Kosterlitz HW, Paterson SJ (1981) Tyr-D-Ala-Gly-MePhe-NH(CH2)2OH is a selective ligand for the μ-opiate binding site. Br J Pharmacol 73: 299 P
Kosterlitz HW, Paterson SJ (1985) Types of opioid receptors: relation to antinociception. Philos Trans R Soc Lond [Biol] 308: 291–297
Kosterlitz HW, Paterson SJ (1990) D-Phe-Cys-Tyr-D-TrP-OrN-Thr-PeN-Thr-NH2 is a highly selective μ-ligand with low in vitro antagonist activity. Br J Pharmacol 99: 291 P
Kosterlitz HW, Lord J AH, Paterson SJ, Waterfield AA (1980) Effect of changes in the structure of enkephalins and of narcotic analgesic drugs on their interaction with and δ-receptors. Br J Pharmacol 68: 333–342
Kosterlitz HW, Corbett AD, Paterson SJ (1990) Opioid receptors and their ligands. In: Harris LS (ed) Problems of drug dependence 1989. Natl Inst Drug Abuse Res Monogr Ser 95: 159–166
Kramer TH, Shook JE, Kazmierski W, Ayres EA, Wire WS, Hruby VJ, Burks TF (1989) Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J Pharmacol Exp Ther 249: 544–551
Kreil G, Barra D, Simmaco M, Erspamer V, Falconieri–Erspamer G, Negri L, Severini C, Corsi R, Melchiorri P (1989) Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for δ opioid receptors. Eur J Pharmacol 162: 123–128
Lahti RA, Mickelson MM, McCall JM, Von Voigtlander (1985) [3H] U-69593, a highly selective ligand for the opioid ĸ-receptor. Eur J Pharmacol 109:281–284
Lazarus LH, Wilson WE, de Castiglione R, Guglietta A (1989) Dermorphin gene sequence peptide with high affinity and selectivity for 5 opioid receptors. J Biol Chem 264: 3047
Lemaire S, Magnan J, Regoli D (1978) Rat vas deferens: a specific bioassay for endogenous opioid peptides. Br J Pharmacol 64: 327–329
Leslie FM (1987) Methods used in the study of opioids. Pharmacol Rev 39: 197–249
Leslie FM, Chavkin C, Cox BM (1980) Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites. J Pharmacol Exp Ther 214: 395–402
Liao CS, Day AR, Freer RJ (1981) Evidence for a single opioid receptor type in the field stimulated rat vas deferens. Life Sci 29: 2617–2622
Lord J AH, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267: 495–499
Magnan J, Paterson SJ, Tavani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedebergs Arch Pharmacol 319: 197–205
Mains RE, Eipper BA, Ling N (1977) Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 74: 3014–3018
McKnight AT, Corbett AD, Paterson SJ, Magnan J, Kosterlitz HW (1982) Comparison of in vitro potencies in pharmacological and binding assays after inhibition of peptidases reveals that dynorphin (1–9) is a potent ĸ-agonist. Life Sci 31: 1725–1728
McKnight AT, Corbett AD, Kosterlitz HW (1983) Increase in potencies of opioid peptides after peptidase inhibition. Eur J Pharmacol 86: 393–402
McKnight AT, Corbett AD, Marcoli M, Kosterlitz HW (1984) Hamster vas deferens contains δ-opioid receptors. Neuropeptides 5: 97–100
McKnight AT, Corbett AD, Marcoli M, Kosterlitz HW (1985) The opioid receptors in the hamster vas deferens are of the δ-type. Neuropharmacology 24: 1011–1017
Meecham KJ, Boyle SJ, Hunter JC, Hughes J (1989) An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302. Eur J Pharmacol 173: 151–157
Miller L, Shaw JS (1985) Characterization of the δ-opioid receptor on the hamster vas deferens. Neuropeptides 6: 531–536
Miller L, Shaw JS, Whiting EM (1986) The contribution of intrinsic activity to the actions of opioids in vitro. Br J Pharmacol 87: 595–601
Mor A, Delfour A, Sagan S, Amiche M, Pradelles P, Rossier J, Nicolas P (1989) Isolation of dermenkephalin from amphibian skin, a high affinity δ-selective opioid heptapeptide containing a D-amino acid residue. FEBS Lett 255:269–274
Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF (1983) Bis-penicillamine enkephalins possess highly improved specificity towards δ opioid receptors. Proc Natl Acad Sci USA 80: 5871–5874
Nakanishi S, Inoue A, Kita T, Nakamura M, Chang ACY, Cohen SM, Numa S (1979) Nucleotide sequence of cloned cDNA for bovine corticotropin-P- lipotropin precursor. Nature 278: 423–427
Noda M, Furutani Y, Takahashi H, Toyosato M, Hirose T, Inayama S, Nakanishi S, Numa S (1982) Cloning and sequence analysis of cDNA for bovine preproenkephalin. Nature 295: 202–206
Oka T, Negishi K, Suda M, Matsumiya T, Inazu T, Masaaki U (1981) Rabbit vas deferens: a specific bioassay for opioid K-recptor agonists. Eur J Pharmacol 73: 235–236
Paterson SJ (1986) Multiple opioid binding sites and their ligands. PhD thesis, University of Aberdeen Paterson SJ (1991) Opioid receptors. In: Stone TW (ed) Aspects of Synaptic Transmission: LTP, galanin, opioids, autonomic and 5-HT, vol 1. Taylor and Francis, London, pp 117–140
Paterson SJ, Robson LE, Kosterlitz HW (1984) Opioid receptors. In: Udenfriend S, Meienhoffer J (eds) The peptides: analysis, synthesis and biology, vol 6. Academic, London, pp 147–189
Pelton JT, Gulya K, Hruby VJ, Duckies SJ, Yamamura HI (1986) Somatostatin analogs with affinity for opiate receptors in rat brain binding assays. Peptides 6 (Suppl 1): 159–163
Porini G, Petrillo P, Colombo M, Tavani A (1990) In vitro binding profile of cyprodime, a reported mu-opioid antagonist. In: van Ree JM, Mulder AH, Wiegant VM, van Wimersma Greidanus TB (eds) New leads in opioid research. Excerpta Medica, Amsterdam, pp 225–227
Portoghese PS, Takemori AE (1985) TEN A, a selective kappa opioid receptor antagonist. Life Sci 36: 810–805
Portoghese PS, Larson DL, Jiang JB, Caruso TP, Takemori AE (1979) Synthesis and pharmacological characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultra-long lasting narcotic antagonist properties. J Med Chem 22: 168–173
Portoghese PS, Larson DL, Sayre DS, Fries DS, Takemori AE (1980) A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J Med Chem 26: 1341–1343
Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and nor- binaltorphimine, potent and selective ĸ-opioid receptor antagonists. Life Sci 40: 1287–1292
Portoghese PS, Sultana M, Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide δ-opioid receptor antagonist. Eur J Pharmacol 146: 185–186
Rezvani A, Höllt V, Way EL (1983) ĸ-Receptor activities of three opioid peptide families. Life Sci 33 (Suppl l):271–274
Roberts JL, Herbert E (1977a) Characterization of a common precursor to corticotropin and β-lipotropin: cell-free synthesis of the precursor and identification of corticotropin peptides in the molecule. Proc Natl Acad Sci USA 74: 4826–4830
Roberts JL, Herbert E (1977b) Characterization of a common precursor to corticotropin and β-lipotropin: identification of P-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system. Proc Natl Acad Sci USA 74: 5300–5304
Römer D, Buscher HH, Hill RC, Pless J, Bauer W, Cardinaux F, Closse A, Hauser D, Huguenin R (1977) A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity. Nature 268: 547–549
Römer D, Buscher H, Hill RC, Maurer R, Petcher TJ, Welle HB, Bakel CCK, Akkerman AM (1980) Bremazocine: a potent, long-acting opiate kappa agonist. Life Sci 27: 971–978
Römer D, Buscher H, Hill RC, Maurer R, Petcher TJ, Zeugner H, Benson W, Finner E, Milkowski W, Thies PW (1982) An opioid benzodiazepine. Nature 298: 759–760
Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW (1991) Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and hamster vas deferens. Br J Pharmacol 104: 428–432
Schiller PW, Nguyen TM-D, Maziak LA, Wilkes BC, Lemieux C (1987) Structure- activity relationships of cyclic opioid peptide analogues containing phenylalanine residue in the 3–position. J Med Chem 30: 2094–2099
Schiller PW, Nguyen TM-D, Chung NN, Lemieux C (1989) Dermorphin analogues carrying an increased positive charge in their “message”1 domain display extremely high μ-opioid receptor selectivity. J Med Chem 32: 698–703
Schmidhammer H, Smith CFC (1989) A simple and efficient method for the preparation of binaltorphimine and derivatives and determination of their K- opioid antagonist selectivity. Helv Chim Acta 72: 675–677
Schmidhammer H, Burkard WP, EggsteiN-Aeppli L, Smith CFC (1989) Synthesis and biological evaluation of 14-alkoxymorphinans: 2. (-)-N- (cyclopropylmethyl)-4, 14–dimethoxymorphinaN-6-one, a selective μ opioid receptor antagonist. J Med Chem 32: 418–421
Schmidt WK, Tam SW, Shotzberger GS, Smith DH, Clark R, Vernier VG (1985) Nalbuphine. Drug Alcohol Depend 14: 339–362
Schulz R, Faase E, Wüster M, Herz A (1979) Selective receptors for P-endorphin in the rat vas deferens. Life Sci 24: 843–849
Schulz R, Wüster M, Herz A (1981) Pharmacological characterization of the ε- receptor. J Pharmacol Exp Ther 216: 604–606
Shaw JS, Miller L, Turnbull MJ, Gormley JJ, Morley JS (1982) Selective antagonists at the opiate delta-receptor. Life Sci 31: 1259–1262
Sheehan MJ, Hayes AG, Tyers MB (1986) Pharmacology of δ-opioid receptors in the hamster vas deferens. Eur J Pharmacol 130: 57–64
Sheehan MJ, Hayes AG, Tyers MB (1988) Lack of evidence for ε-opioid receptors in the rat vas deferens. Eur J Pharmacol 154: 237–245
Shi P, Niu J, Wu S, Zou G (1981) Enkephalin analogs with extremely high affinity for δ-receptor. Kexue Tongbao 26: 750–752
Shimohigashi Y, Costa T, Matsuura S, Chen H-C, Rodbard D (1982) Dimeric enkephalins display affinity and selectivity for the delta opiate receptor. Mol Pharmacol 21: 558–563
Shimohigashi Y, Costa T, Pfeiffer A, Herz A, Kimura H, Stammer CH (1987) E Phe4–enkephalin analogs. Delta receptors in rat brain are different from those in mouse vas deferens. FEBS Lett 222: 71–74
Shimohigashi Y, Takano Y, Kamiya H, Costa T, Herz A, Stammer CH (1988) A highly selective ligand for brain δ opiate receptors, a E Phe4-enkephalin analog, suppresses μ receptor-mediated thermal analgesia by morphine. FEBS Lett 233: 289–229
Smith CFC (1987) 16-Me-Cyprenorphine (RX 8008M): a potent opioid antagonist with some δ selectivity. Life Sci 40:267–274
Takemori AE, Begonia YH, Naeseth JS, Portoghese PS (1988) Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesia and receptor binding assays. J Pharmacol Exp Ther 246: 255–258
Toth G, Kramer TH, Knapp R, Lui G, Davis P, Burks TF, Yamamura HI, Hruby VJ (1989) [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for δ-opioid receptors. J Med Chem 33:249–253
Traynor JR, Corbett AD, Kosterlitz HW (1987) Diprenorphine has agonist activity at opioid ĸ-receptors in the myenteric plexus of the guinea-pig ileum. Eur J Pharmacol 137: 85–89
Vaughn LK, Knapp RJ, Toth G, Wan Y-P, Hruby VJ, Yamamura HI (1989) A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2,/pC1- Phe4,D-Pen5]enkephalin. Life Sci 45: 1001–1008
Vaughn LK, Wire SW, Davis P, Shimohigashi Y, Toth G, Knapp RJ, Hruby VJ, Burks TF, Yamamura HI (1990) Differentiation between rat brain and mouse vas deferens δ-opioid receptors. Eur J Pharmacol 177: 99–101
Von Voigtlander PF, Lahti RA, Ludens JH (1983) U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 224:7–12
Weber E, Esch FS, Bohlen P, Paterson SJ, Corbett AD, McKnight AT, Kosterlitz HW, Barchas JD, Evans CJ (1983) Metorphamide: isolation, structure, and biological activity of an amidated opioid octapeptide from bovine brain. Proc Natl Acad Sci USA 80: 7362–7366
Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A (1986) Morphine and codeine from mammalian brain. Proc Natl Acad Sci USA 83: 9784–9788
Weitz CJ, Faull KF, Goldstein A (1987) Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature 330: 674–677
Wüster M, Schulz R, Herz A (1979) Selectivity of opioids towards the μ-, and δ-opiate receptors. Neurosci Lett 15: 193–198
Yeadon M, Kitchen I (1988) Comparative binding of μ and δ selective ligands in whole brain and pons/medulla from rat: affinity profiles of fentanyl derivatives. Neuropharmacology 27: 345–348
Zajac JM, Gacel G, Petit F, Dodey P, Rossignol P, Roques B (1983) Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate δ-receptors. Biochem Biophys Res Commun 111: 390–397